| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/16/2011 | WO2011071095A1 Benzamide compound |
| 06/16/2011 | WO2011071048A1 Heteroarylcarboxylic acid ester derivative |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |
| 06/16/2011 | WO2011070039A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
| 06/16/2011 | WO2011070029A1 Amino oxazine derivatives |
| 06/16/2011 | WO2011069958A2 Low caloric fat replacers |
| 06/16/2011 | WO2011069527A1 Treatment scheme for idd and other automimmune diseases |
| 06/16/2011 | WO2011069298A1 Novel cyclopropane indolinone derivatives |
| 06/16/2011 | WO2011048616A3 Healthy sugar and process for preparation of the same |
| 06/16/2011 | WO2011031063A9 Composition for preventing or treating metabolic disorders, containing the anti-4-1bb antibody |
| 06/16/2011 | WO2011028344A3 Interleukin-1 receptor antagonist compositions and methods of making and using same |
| 06/16/2011 | WO2011022056A3 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 06/16/2011 | WO2011020095A3 Compositions and methods of treating inflammation |
| 06/16/2011 | WO2011011847A3 Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases |
| 06/16/2011 | WO2010148533A8 A pharmaceutical composition with the effect of treating diabetes |
| 06/16/2011 | WO2010136900A3 Methods of using krill oil to treat risk factors for metabolic disorders and obesity |
| 06/16/2011 | US20110145941 Antibodies and derivatives thereof |
| 06/16/2011 | US20110144309 Manipulation of Cytokine Levels Using CD83 Gene Products |
| 06/16/2011 | US20110144196 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof |
| 06/16/2011 | US20110144178 1 ,6-dihydro-2h-3-oxa-6-aza-as-indacene compounds |
| 06/16/2011 | US20110144164 Pyridone derivatives as NK3 antagonists |
| 06/16/2011 | US20110144162 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/16/2011 | US20110144157 Pyrrole derivatives, preparation of same and therapeutic application thereof |
| 06/16/2011 | US20110144153 Amide compound |
| 06/16/2011 | US20110144145 Methods for treating visceral fat conditions |
| 06/16/2011 | US20110144138 Substituted pyrimido isoquinoline derivatives |
| 06/16/2011 | US20110144134 Anti-Inflammatory Pyrazolopyrimndines |
| 06/16/2011 | US20110144132 Substituted pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144129 3-Aminocyclopentanecarboxamides as Chemokine Receptor Agonists |
| 06/16/2011 | US20110144123 Thiazoles and Oxazoles Useful as Modulators of ATP-Binding Cassette Transporters |
| 06/16/2011 | US20110144117 Pharmaceutical Dosage Form Containing Tetrahydrobiopterin |
| 06/16/2011 | US20110144115 Substituted 1-benzyl-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/16/2011 | US20110144114 Substituted triazinone derivatives |
| 06/16/2011 | US20110144105 Azaindole glucokinase activators |
| 06/16/2011 | US20110144101 Macrocyclic compounds useful as pharmaceuticals |
| 06/16/2011 | US20110144098 Amino oxazine derivatives |
| 06/16/2011 | US20110144097 2-amino-5,5-difluoro-5,6-dihydro-4h-[1,3]oxazin-4-yl)-phenyl]-amides |
| 06/16/2011 | US20110144096 Treating various disorders using trkb agonists |
| 06/16/2011 | US20110144095 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144091 Inhibitors of Diacylglycerol Acyltransferase |
| 06/16/2011 | US20110144090 Compounds and methods of use thereof |
| 06/16/2011 | US20110144083 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 06/16/2011 | US20110144078 Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
| 06/16/2011 | US20110144076 Preterm delivery diagnostic assay |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
| 06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
| 06/16/2011 | US20110144055 Health Care |
| 06/16/2011 | US20110144052 Niacin prodrugs and deuterated versions thereof |
| 06/16/2011 | US20110144051 Compositions and methods for treatment of mitochondrial diseases |
| 06/16/2011 | US20110144042 Novel Polysaccharides with Antithrombotic Activity Comprising at Least One Covalent Bond with Biotin or a Biotin Derivative |
| 06/16/2011 | US20110144039 Antioxidative and hepatoprotective compositions containing diaryheptanoids from alnus japonica |
| 06/16/2011 | US20110144012 Shortened glucagon-like peptide 1(sglp-1) preparation method and application |
| 06/16/2011 | US20110144011 Cellular Activation Insulin Therapy |
| 06/16/2011 | US20110144010 Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier |
| 06/16/2011 | US20110144009 Brown Adipocyte Progenitors in Human Skeletal Muscle |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/16/2011 | US20110144007 Glucose-dependent insulinotropic polypeptide analogues |
| 06/16/2011 | US20110144006 Protein composition |
| 06/16/2011 | US20110143994 Compositions and methods for treatment of autoimmune and allergic diseases |
| 06/16/2011 | US20110142973 Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus |
| 06/16/2011 | US20110142971 Use of an onion extract for making a composition to control weight gain |
| 06/16/2011 | US20110142967 Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent |
| 06/16/2011 | US20110142938 Nanotubes as Mitochondrial Uncouplers |
| 06/16/2011 | US20110142932 Pharmaceutical Tablets Comprising a Plurality of Segments |
| 06/16/2011 | US20110142930 Pharmaceutical Compositions of Atorvastatin |
| 06/16/2011 | US20110142928 Process for the production of calcium compositions in a continuous fluid bed |
| 06/16/2011 | US20110142926 Nanoparticles for protein drug delivery |
| 06/16/2011 | US20110142920 Treatment of length dependent neuropathy |
| 06/16/2011 | US20110142915 Compositions and methods for inhibition of vegf |
| 06/16/2011 | US20110142914 Inhalable compositions having enhanced bioavailability |
| 06/16/2011 | US20110142901 Sustained release composition |
| 06/16/2011 | US20110142889 Compositions and methods for oral drug delivery |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142884 Materials and Methods for Making Improved Micelle Compositions |
| 06/16/2011 | US20110142881 Transcutaneous delivery of therapeutic agents |
| 06/16/2011 | US20110142880 Lentivirus-based immunogenic vectors |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142850 Method of treating cd40-mediated diseases |
| 06/16/2011 | US20110142849 Pcsk9 antagonists |
| 06/16/2011 | US20110142821 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 06/16/2011 | US20110142818 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 06/16/2011 | US20110142808 Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells |
| 06/16/2011 | US20110142801 Protease resistant modified interferon-beta polypeptides and their use in treating diseases |
| 06/16/2011 | US20110142800 Methods and compositions for oral administration of proteins |
| 06/16/2011 | US20110142787 Polymerized cyclic nitroxide radical compound and use thereof |
| 06/16/2011 | US20110142766 Effervescent Multi-Vitamin Formulation and Methods of Use Thereof |
| 06/16/2011 | US20110142761 Il-1 binding proteins |
| 06/16/2011 | US20110139654 Oxadiazole derivatives for the treatment of diabetes |
| 06/16/2011 | US20110138888 Treatment of obesity |
| 06/16/2011 | CA2785996A1 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 06/16/2011 | CA2783763A1 Insulin analogues with chlorinated amino acids |
| 06/16/2011 | CA2783684A1 Inhibitors of diacylglycerol acyltransferase |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2782420A1 Human antigen binding proteins that bind .beta.-klotho, fgf receptors and complexes thereof |
| 06/16/2011 | CA2781839A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
| 06/16/2011 | CA2781050A1 Pcsk9 antagonists |
| 06/16/2011 | CA2780693A1 Amino oxazine derivatives |
| 06/15/2011 | EP2333052A1 Desaturase genes and uses thereof |